<?xml version="1.0"?>
<rss version="2.0" xml:base="link" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:fb="http://www.facebook.com/2008/fbml" xmlns:foaf="http://xmlns.com/foaf/0.1/" xmlns:media="http://www.rssboard.org/media-rss" xmlns:og="http://ogp.me/ns#" xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#" xmlns:schema="http://schema.org/" xmlns:sioc="http://rdfs.org/sioc/ns#" xmlns:sioct="http://rdfs.org/sioc/types#" xmlns:skos="http://www.w3.org/2004/02/skos/core#" xmlns:xsd="http://www.w3.org/2001/XMLSchema">
  <channel>
    <title>Nathan Bartlett - South China Morning Post</title>
    <link>https://www.scmp.com/rss/508624/feed</link>
    <description>Nathan Bartlett is Associate Professor, School of Biomedical Sciences and Pharmacy, University of Newcastle in Australia, and head of the Viral Immunology and Respiratory Disease group. He is based at the Hunter Medical Research Institute. He also retains an honorary academic appointment at Imperial College London, UK to continue collaborative research.</description>
    <language>en</language>
    <image>
      <url>https://assets.i-scmp.com/static/img/icons/scmp-meta-1200x630.png</url>
      <title>Nathan Bartlett - South China Morning Post</title>
      <link>https://www.scmp.com</link>
    </image>
    <atom:link href="https://www.scmp.com/rss/508624/feed" rel="self" type="application/rss+xml"/>
    <item>
      <description>Last week, the chief executive of Pfizer said anyone who receives its Covid-19 vaccine will probably need to have a third dose within 6-12 months after being fully immunised, and then likely one dose every year going forward.
We’ll need these because it’s likely that, for many of us, immunity will begin to wane within that time frame. The vaccine will also need to be tweaked to cover new coronavirus variants as they emerge.
The advantage of mRNA vaccines like Pfizer’s is they’re much easier to...</description>
      <guid isPermaLink="true">https://www.scmp.com/week-asia/opinion/article/3130279/why-mrna-covid-19-vaccines-pfizers-jab-should-be-part-long-term?utm_source=rss_feed</guid>
      <link>https://www.scmp.com/week-asia/opinion/article/3130279/why-mrna-covid-19-vaccines-pfizers-jab-should-be-part-long-term?utm_source=rss_feed</link>
      <pubDate>Tue, 20 Apr 2021 09:00:21 +0000</pubDate>
      <title>Why mRNA Covid-19 vaccines like Pfizer’s jab should be part of a long-term public health strategy</title>
      <enclosure length="5567" type="image/jpeg" url="https://cdn.i-scmp.com/sites/default/files/styles/1280x720/public/d8/images/canvas/2021/04/20/e862ada6-d1a9-420f-9733-1cf66f76ec4a_576ba523.jpg?itok=XQOAQIv8&amp;v=1618905796"/>
      <media:content height="3711" medium="image" type="image/jpeg" url="https://cdn.i-scmp.com/sites/default/files/styles/1280x720/public/d8/images/canvas/2021/04/20/e862ada6-d1a9-420f-9733-1cf66f76ec4a_576ba523.jpg?itok=XQOAQIv8&amp;v=1618905796" width="5567"/>
    </item>
    <item>
      <description>Reports of about 30 deaths among elderly nursing home residents who received the Pfizer-BioNTech vaccine have made international headlines.
With Australia’s Therapeutic Goods Administration (TGA) expected to approve the vaccine imminently and the roll out set to begin next month, this development might seem like cause for concern around the safety of the vaccine.
But there are a few reasons it shouldn’t be.
Norway raises concern over Pfizer vaccine jabs for elderly, Australia seeks...</description>
      <guid isPermaLink="true">https://www.scmp.com/week-asia/opinion/article/3118325/pfizer-coronavirus-vaccine-and-frail-people-too-early-make-firm?utm_source=rss_feed</guid>
      <link>https://www.scmp.com/week-asia/opinion/article/3118325/pfizer-coronavirus-vaccine-and-frail-people-too-early-make-firm?utm_source=rss_feed</link>
      <pubDate>Tue, 19 Jan 2021 09:00:13 +0000</pubDate>
      <title>Pfizer coronavirus vaccine and frail people: too early to make firm conclusions</title>
      <enclosure length="3607" type="image/jpeg" url="https://cdn.i-scmp.com/sites/default/files/styles/1280x720/public/d8/images/methode/2021/01/19/b2b3aa72-5a2b-11eb-a99a-beae699a1a1d_image_hires_171220.jpg?itok=wPBktYuQ&amp;v=1611047550"/>
      <media:content height="2259" medium="image" type="image/jpeg" url="https://cdn.i-scmp.com/sites/default/files/styles/1280x720/public/d8/images/methode/2021/01/19/b2b3aa72-5a2b-11eb-a99a-beae699a1a1d_image_hires_171220.jpg?itok=wPBktYuQ&amp;v=1611047550" width="3607"/>
    </item>
  </channel>
</rss>